Rajesh Krishnan Oncternal Therapeutics, Inc. (ONCT) insider trading activity

ONCT Quotes by TradingView

Rajesh Krishnan is CTO/CSO of Oncternal Therapeutics, Inc.. Currently has a direct ownership of 44,019 shares of ONCT, which is worth approximately $23,330. The most recent transaction as insider was on Jan 03, 2024, when has been sold 11,838 shares (Common Stock) at a price of $0.5 per share, resulting in proceeds of $5,919. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44K
0% 3M change
21.19% 12M change
Total Value Held $23,330

Rajesh Krishnan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2024
SELL
Payment of exercise price or tax liability
$5,919 $0.5 p/Share
11,838 Reduced 21.19%
44,019 Common Stock
Jul 03 2023
SELL
Payment of exercise price or tax liability
$3,922 $0.36 p/Share
10,897 Reduced 16.32%
55,857 Common Stock
Jan 03 2023
SELL
Payment of exercise price or tax liability
$6,362 $1.02 p/Share
6,238 Reduced 8.55%
66,754 Common Stock
Jul 28 2022
BUY
Grant, award, or other acquisition
-
43,125 Added 37.14%
72,992 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
29,867 Added 50.0%
29,867 Common Stock
RK

Rajesh Krishnan

CTO/CSO
San Diego, CA

Track Institutional and Insider Activities on ONCT

Follow Oncternal Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ONCT shares.

Notify only if

Insider Trading

Get notified when an Oncternal Therapeutics, Inc. insider buys or sells ONCT shares.

Notify only if

News

Receive news related to Oncternal Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ONCT